• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在稳定表达 5-羟色胺(5-HT)5-HT2A 或 5-HT2C 受体的 CHO 细胞中同时测量细胞内钙和细胞外调节激酶激活的定量变化。

Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors.

机构信息

Center for Addiction Research, University of Texas Medical Branch, Galveston, TX 77555, USA.

出版信息

BMC Neurosci. 2012 Mar 7;13:25. doi: 10.1186/1471-2202-13-25.

DOI:10.1186/1471-2202-13-25
PMID:22397586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3380724/
Abstract

BACKGROUND

The serotonin (5-HT) 2A and 2C receptors (5-HT2AR and 5-HT2CR) are involved in a wide range of physiological and behavioral processes in the mammalian central and peripheral nervous systems. These receptors share a high degree of homology, have overlapping pharmacological profiles, and utilize many of the same and richly diverse second messenger signaling systems. We have developed quantitative assays for cells stably expressing these two receptors involving minimal cell sample manipulations that dramatically improve parallel assessments of two signaling responses: intracellular calcium (Cai++) changes and activation (phosphorylation) of downstream kinases. Such profiles are needed to begin to understand the simultaneous contributions from the multiplicity of signaling cascades likely to be initiated by serotonergic ligands.

RESULTS

We optimized the Cai++ assay for stable cell lines expressing either 5-HT2AR or 5-HT2CR (including dye use and measurement parameters; cell density and serum requirements). We adapted a quantitative 96-well plate immunoassay for pERK in the same cell lines. Similar cell density optima and time courses were observed for 5-HT2AR- and 5-HT2CR-expressing cells in generating both types of signaling. Both cell lines also require serum-free preincubation for maximal agonist responses in the pERK assay. However, 5-HT2AR-expressing cells showed significant release of Cai++ in response to 5-HT stimulation even when preincubated in serum-replete medium, while the response was completely eliminated by serum in 5-HT2CR-expressing cells. Response to another serotonergic ligand (DOI) was eliminated by serum-replete preincubation in both cells lines.

CONCLUSIONS

These data expand our knowledge of differences in ligand-stimulated signaling cascades between 5-HT2AR and 5-HT2CR. Our parallel assays can be applied to other cell and receptor systems for monitoring and dissecting concurrent signaling responses.

摘要

背景

血清素(5-HT)2A 和 2C 受体(5-HT2AR 和 5-HT2CR)参与哺乳动物中枢和外周神经系统的广泛生理和行为过程。这些受体具有高度同源性,具有重叠的药理学特征,并利用许多相同的和丰富多样的第二信使信号转导系统。我们已经开发了用于稳定表达这些两种受体的细胞的定量测定法,涉及最小的细胞样本操作,这些操作极大地改善了两种信号反应的平行评估:细胞内钙(Cai++)变化和下游激酶的激活(磷酸化)。需要这种谱来开始理解可能由 5-羟色胺能配体引发的多重信号级联的同时贡献。

结果

我们优化了用于稳定表达 5-HT2AR 或 5-HT2CR 的细胞系的 Cai++测定法(包括染料使用和测量参数;细胞密度和血清要求)。我们在相同的细胞系中适应了用于 pERK 的定量 96 孔板免疫测定法。在产生两种类型的信号时,观察到 5-HT2AR 和 5-HT2CR 表达细胞的相似细胞密度最佳值和时间过程。这两种细胞系在 pERK 测定中也需要无血清预孵育以获得最大激动剂反应。然而,即使在富含血清的培养基中预孵育,5-HT2AR 表达细胞也会对 5-HT 刺激表现出显着的 Cai++释放,而在 5-HT2CR 表达细胞中,该反应则完全被血清消除。另一种 5-羟色胺能配体(DOI)的反应也被两种细胞系的富含血清预孵育消除。

结论

这些数据扩展了我们对 5-HT2AR 和 5-HT2CR 之间配体刺激信号级联差异的认识。我们的平行测定法可应用于其他细胞和受体系统,用于监测和剖析并发信号反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/95a467f9c26e/1471-2202-13-25-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/a85827f33b9b/1471-2202-13-25-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/a3e3efe9bf50/1471-2202-13-25-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/7325d28baa88/1471-2202-13-25-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/b33829a5c0c4/1471-2202-13-25-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/0aca913b1825/1471-2202-13-25-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/7804c3bf6f63/1471-2202-13-25-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/95a467f9c26e/1471-2202-13-25-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/a85827f33b9b/1471-2202-13-25-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/a3e3efe9bf50/1471-2202-13-25-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/7325d28baa88/1471-2202-13-25-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/b33829a5c0c4/1471-2202-13-25-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/0aca913b1825/1471-2202-13-25-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/7804c3bf6f63/1471-2202-13-25-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e94d/3380724/95a467f9c26e/1471-2202-13-25-7.jpg

相似文献

1
Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors.在稳定表达 5-羟色胺(5-HT)5-HT2A 或 5-HT2C 受体的 CHO 细胞中同时测量细胞内钙和细胞外调节激酶激活的定量变化。
BMC Neurosci. 2012 Mar 7;13:25. doi: 10.1186/1471-2202-13-25.
2
Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction.血清素 5-HT2A 和 5-HT2C 受体相互作用的生物物理验证。
PLoS One. 2018 Aug 29;13(8):e0203137. doi: 10.1371/journal.pone.0203137. eCollection 2018.
3
Endogenous 5-HT2C Receptors Phosphorylate the cAMP Response Element Binding Protein via Protein Kinase C-Promoted Activation of Extracellular-Regulated Kinases-1/2 in Hypothalamic mHypoA-2/10 Cells.内源性5-HT2C受体通过蛋白激酶C促进的细胞外调节激酶-1/2激活,使下丘脑mHypoA-2/10细胞中的环磷酸腺苷反应元件结合蛋白发生磷酸化。
J Pharmacol Exp Ther. 2016 Jul;358(1):39-49. doi: 10.1124/jpet.116.232397. Epub 2016 Apr 26.
4
Coevolution of Residues Provides Evidence of a Functional Heterodimer of 5-HTR and 5-HTR Involving Both Intracellular and Extracellular Domains.残基的协同进化为 5-HTR 和 5-HTR 的功能异二聚体提供了证据,涉及细胞内和细胞外结构域。
Neuroscience. 2019 Aug 1;412:48-59. doi: 10.1016/j.neuroscience.2019.05.013. Epub 2019 Jun 1.
5
Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.重组人5-HT2A、5-HT2B和5-HT2C受体激动剂在CHO-K1细胞中的功能特性研究
Br J Pharmacol. 1999 Sep;128(1):13-20. doi: 10.1038/sj.bjp.0702751.
6
Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2.
J Neurochem. 2005 Jun;93(6):1603-15. doi: 10.1111/j.1471-4159.2005.03161.x.
7
Serotonin (5-HT) 5-HT2A Receptor (5-HT2AR):5-HT2CR Imbalance in Medial Prefrontal Cortex Associates with Motor Impulsivity.血清素(5-羟色胺,5-HT)5-HT2A受体(5-HT2AR):内侧前额叶皮质中5-HT2AR失衡与运动冲动性相关。
ACS Chem Neurosci. 2015 Jul 15;6(7):1248-58. doi: 10.1021/acschemneuro.5b00094. Epub 2015 Jul 7.
8
Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.
Naunyn Schmiedebergs Arch Pharmacol. 2009 May;379(5):461-71. doi: 10.1007/s00210-008-0378-4. Epub 2008 Dec 5.
9
Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.5-羟色胺2受体亚型的均相高亲和力激动剂结合分析方法的开发。
Assay Drug Dev Technol. 2005 Dec;3(6):649-59. doi: 10.1089/adt.2005.3.649.
10
Endogenous Serotonin 5-HT and 5-HT Receptors Associate in the Medial Prefrontal Cortex.内源性血清素 5-HT 与 5-HT 受体在额前皮质中结合。
ACS Chem Neurosci. 2019 Jul 17;10(7):3241-3248. doi: 10.1021/acschemneuro.8b00669. Epub 2019 Mar 18.

引用本文的文献

1
Discovery of a peripheral 5HT antagonist as a clinical candidate for metabolic dysfunction-associated steatohepatitis.发现外周 5HT 拮抗剂可作为代谢功能障碍相关脂肪性肝炎的临床候选药物。
Nat Commun. 2024 Jan 20;15(1):645. doi: 10.1038/s41467-024-44874-3.
2
Hypothalamic TRH mediates anorectic effects of serotonin in rats.下丘脑促甲状腺激素释放激素介导大鼠体内血清素的食欲抑制作用。
eNeuro. 2022 May 11;9(3). doi: 10.1523/ENEURO.0077-22.2022.
3
Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties.

本文引用的文献

1
Synthesis and evaluation of dimeric derivatives of 5-HT(2A) receptor (5-HT(2A)R) antagonist M-100907.5-羟色胺2A受体(5-HT(2A)R)拮抗剂M-100907二聚体衍生物的合成与评价
ACS Chem Neurosci. 2011 Nov 16;2(11):640-644. doi: 10.1021/cn200077q.
2
Cell-based calcium assay for medium to high throughput screening of TRP channel functions using FlexStation 3.使用FlexStation 3进行基于细胞的钙检测,用于中高通量筛选瞬时受体电位(TRP)通道功能。
J Vis Exp. 2011 Aug 17(54):3149. doi: 10.3791/3149.
3
Molecular basis of NMDA receptor functional diversity.
发现 4-苯哌啶-2-甲酰胺类似物作为血清素 5-HT 受体正变构调节剂,具有增强的类药性。
J Med Chem. 2020 Jul 23;63(14):7529-7544. doi: 10.1021/acs.jmedchem.9b01953. Epub 2020 Jul 7.
4
and Analyses of Novel Peptidomimetic Disruptors for the Serotonin 5-HT Receptor Interaction With Phosphatase and Tensin Homolog.新型拟肽干扰物对5-羟色胺5-HT受体与磷酸酶及张力蛋白同源物相互作用的分析
Front Pharmacol. 2019 Aug 23;10:907. doi: 10.3389/fphar.2019.00907. eCollection 2019.
5
Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development.在生物背景下靶向 5-HT2C 受体及 5-HT2C 受体配体研发的现状
Curr Top Med Chem. 2019;19(16):1381-1398. doi: 10.2174/1568026619666190709101449.
6
Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction.血清素 5-HT2A 和 5-HT2C 受体相互作用的生物物理验证。
PLoS One. 2018 Aug 29;13(8):e0203137. doi: 10.1371/journal.pone.0203137. eCollection 2018.
7
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.变构调节 A 类 G 蛋白偶联受体:靶点、药物及新的概念。
J Med Chem. 2019 Jan 10;62(1):88-127. doi: 10.1021/acs.jmedchem.8b00875. Epub 2018 Aug 28.
8
Xenoestrogen interference with nongenomic signaling actions of physiological estrogens in endocrine cancer cells.异种雌激素对内分泌癌细胞中生理雌激素非基因组信号传导作用的干扰。
Steroids. 2019 Feb;142:84-93. doi: 10.1016/j.steroids.2018.06.014. Epub 2018 Jul 20.
9
Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT Receptor.设计、合成及十一烷基哌啶-2-甲酰胺类化合物作为血清素(5-HT)5-HT 受体正变构调节剂的结构鉴定。
J Med Chem. 2019 Jan 10;62(1):288-305. doi: 10.1021/acs.jmedchem.8b00401. Epub 2018 Apr 13.
10
Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT receptor (5-HTR) antagonist M100907.血清素(5-羟色胺,5-HT)5-HT受体(5-HTR)拮抗剂M100907的功能化衍生物的合成与活性
Bioorg Med Chem Lett. 2018 May 1;28(8):1381-1385. doi: 10.1016/j.bmcl.2018.02.058. Epub 2018 Mar 16.
NMDA 受体功能多样性的分子基础。
Eur J Neurosci. 2011 Apr;33(8):1351-65. doi: 10.1111/j.1460-9568.2011.07628.x. Epub 2011 Mar 14.
4
Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.5-羟色胺 2C 受体在 G 蛋白非依赖性信号传导中的组成型活性:RNA 编辑和抗抑郁药的调节。
Mol Pharmacol. 2010 Nov;78(5):818-26. doi: 10.1124/mol.110.066035. Epub 2010 Aug 10.
5
Induction and regulation of differentiation in neural stem cells on ultra-nanocrystalline diamond films.诱导和调节神经干细胞在超纳米金刚石薄膜上的分化。
Biomaterials. 2010 Jul;31(21):5575-87. doi: 10.1016/j.biomaterials.2010.03.061. Epub 2010 Apr 27.
6
Functional expression of 5-HT2A receptor in osteoblastic MC3T3-E1 cells.5-HT2A 受体在成骨细胞 MC3T3-E1 细胞中的功能表达。
Biochem Biophys Res Commun. 2010 May 28;396(2):278-82. doi: 10.1016/j.bbrc.2010.04.078. Epub 2010 Apr 23.
7
Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex.5-羟色胺 5-HT2C 受体蛋白表达在大鼠皮质的突触体和突触后区富集。
J Neurochem. 2010 Jun;113(6):1504-15. doi: 10.1111/j.1471-4159.2010.06694.x. Epub 2010 Mar 24.
8
p90 Ribosomal S6 kinase 2, a novel GPCR kinase, is required for growth factor-mediated attenuation of GPCR signaling.p90 核糖体 S6 激酶 2,一种新型的 G 蛋白偶联受体激酶,是生长因子介导的 G 蛋白偶联受体信号转导衰减所必需的。
Biochemistry. 2010 Mar 30;49(12):2657-71. doi: 10.1021/bi901921k.
9
Arrestin orchestrates crosstalk between G protein-coupled receptors to modulate the spatiotemporal activation of ERK MAPK.阻抑蛋白通过协调 G 蛋白偶联受体之间的相互作用来调节 ERK MAPK 的时空激活。
Circ Res. 2010 Jan 8;106(1):79-88. doi: 10.1161/CIRCRESAHA.109.198580. Epub 2009 Nov 19.
10
Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells - the involvement of rapidly activated kinases and caspases.膳食水平的植物雌激素对大鼠垂体GH3/B6/F10细胞的增殖和抗增殖作用——快速激活的激酶和半胱天冬酶的参与
BMC Cancer. 2009 Sep 18;9:334. doi: 10.1186/1471-2407-9-334.